Seeking Alpha

Ralcorp (RAH +4.4%) rejects ConAgra's (CAG +1.7%) $4.9B buyout offer and adopts a poison pill...

Ralcorp (RAH +4.4%) rejects ConAgra's (CAG +1.7%) $4.9B buyout offer and adopts a poison pill defense to prevent outside control of the company. "We are confident that Ralcorp has a strategic plan and a proven management team that will continue to generate significant shareholder value in the future," Ralcorp Chairman William Stiritz says.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|